Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2021 Financial Results

Vir Biotechnology Inc. (VIR) Tops Q2 EPS by 94c

August 5, 2021 4:34 PM EDT

Vir Biotechnology Inc. (NASDAQ: VIR) reported Q2 EPS of $0.46, $0.94 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $177.07 million versus the consensus estimate of $84.56 million.

Vir made strong progress this quarter across our extensive infectious disease portfolio, the most notable of which is that our monoclonal antibody sotrovimab is now available for patients who become ill with COVID-19... More